172 related articles for article (PubMed ID: 36096160)
1. BChE inhibitors from marine organisms - A review.
Lins Alves LK; Cechinel Filho V; de Souza RLR; Furtado-Alle L
Chem Biol Interact; 2022 Nov; 367():110136. PubMed ID: 36096160
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening.
Williams A; Zhou S; Zhan CG
Bioorg Med Chem Lett; 2019 Dec; 29(24):126754. PubMed ID: 31708262
[TBL] [Abstract][Full Text] [Related]
3. Naturally Occurring Cholinesterase Inhibitors from Plants, Fungi, Algae, and Animals: A Review of the Most Effective Inhibitors Reported in 2012-2022.
Murray AP; Biscussi B; Cavallaro V; Donozo M; Rodriguez SA
Curr Neuropharmacol; 2024; 22(10):1621-1649. PubMed ID: 37357520
[TBL] [Abstract][Full Text] [Related]
4. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel carboxamide- and carbohydrazide-benzimidazoles as selective butyrylcholinesterase inhibitors.
Ozturk O; Farouk FM; Ooi L; Law CSW; Muhammed MT; Aki-Yalcin E; Yeong KY
Mol Divers; 2022 Oct; 26(5):2863-2876. PubMed ID: 35780204
[TBL] [Abstract][Full Text] [Related]
6. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
[TBL] [Abstract][Full Text] [Related]
7. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
8. Biphenylalkoxyamine Derivatives-Histamine H
Łażewska D; Zaręba P; Godyń J; Doroz-Płonka A; Frank A; Reiner-Link D; Bajda M; Stary D; Mogilski S; Olejarz-Maciej A; Kaleta M; Stark H; Malawska B; Kieć-Kononowicz K
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208297
[TBL] [Abstract][Full Text] [Related]
9. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
Gao H; Jiang Y; Zhan J; Sun Y
Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
[TBL] [Abstract][Full Text] [Related]
12. Anti-ovarian cancer potential, in silico studies, and anti-Alzheimer's disease effects of some natural compounds as cholinesterase inhibitors.
Fu M; Ji C; Yang T; Mao F; Shati AA; El-Kott AF; El-Maksoud MMA; Negm S; Ji Y
Biotechnol Appl Biochem; 2023 Jun; 70(3):1085-1099. PubMed ID: 36515452
[TBL] [Abstract][Full Text] [Related]
13. Honeys as Possible Sources of Cholinesterase Inhibitors.
Szwajgier D; Baranowska-Wójcik E; Winiarska-Mieczan A; Gajowniczek-Ałasa D
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889933
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of Fmoc-amino esters and amides bearing a substrate like quaternary ammonium group as selective butyrylcholinesterase inhibitors.
Godinez J; Lee CY; Schwans JP
Bioorg Med Chem Lett; 2023 Aug; 92():129392. PubMed ID: 37364726
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
[TBL] [Abstract][Full Text] [Related]
16. Marine-Derived Compounds with Anti-Alzheimer's Disease Activities.
Hafez Ghoran S; Kijjoa A
Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436249
[TBL] [Abstract][Full Text] [Related]
17. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Kumar A; Pintus F; Di Petrillo A; Medda R; Caria P; Matos MJ; Viña D; Pieroni E; Delogu F; Era B; Delogu GL; Fais A
Sci Rep; 2018 Mar; 8(1):4424. PubMed ID: 29535344
[TBL] [Abstract][Full Text] [Related]
18. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitors.
Ghobadian R; Nadri H; Moradi A; Bukhari SNA; Mahdavi M; Asadi M; Akbarzadeh T; Khaleghzadeh-Ahangar H; Sharifzadeh M; Amini M
Bioorg Med Chem; 2018 Sep; 26(17):4952-4962. PubMed ID: 30190181
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of aromatic tertiary amine derivatives as selective butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Lu X; Qin N; Liu Y; Du C; Feng F; Liu W; Chen Y; Sun H
Eur J Med Chem; 2022 Dec; 243():114729. PubMed ID: 36084535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]